RESUMO
Patient confidentiality is an important issue for treating clinician regardless of the cultural background. Though cultural and religious issues may have an impact on the confidentiality standards. This article discusses the confidentiality standards in Egypt citing the laws and ethical codes governing them. This is followed by a research study in which a questionnaire containing ten vignettes representing different common themes confronted by the practicing clinician was completed by forty-one Egyptian psychiatrists. They checked off categories representing alternatives they might choose dealing with the themes. Each respondent received a score. The scores were compared with those of American and Israeli psychiatrists who participated in a similar study. There were no statistically significant differences though Egyptian and Israeli psychiatrists appear to be somewhat more inclined to break confidentiality. However, significant differences were found to exist for some of the vignettes between the three groups.
Assuntos
Confidencialidade , Padrões de Prática Médica/normas , Psiquiatria , Adulto , Códigos de Ética , Características Culturais , Diversidade Cultural , Egito , Feminino , Humanos , Internacionalidade , Israel , Masculino , Padrões de Prática Médica/estatística & dados numéricos , Religião e Medicina , Inquéritos e Questionários , Estados UnidosAssuntos
Comportamento Perigoso/prevenção & controle , Serviço Hospitalar de Emergência , Serviços de Emergência Psiquiátrica , Armas de Fogo , Transtornos Mentais/psicologia , Serviços de Saúde Mental , Violência/prevenção & controle , Adulto , Feminino , Hospitais com mais de 500 Leitos , Humanos , Masculino , Transtornos Mentais/terapia , Pessoa de Meia-Idade , New Jersey , Admissão do Paciente , Medidas de SegurançaRESUMO
The reported study identifies the socio-demographic profile of the patient who presents himself to the emergency room of an inner city hospital with a history of recent cocaine use; and investigates the patterns of cocaine abuse.
Assuntos
Cocaína , Transtornos Relacionados ao Uso de Substâncias/epidemiologia , População Urbana , Adulto , Estudos Transversais , Serviços de Emergência Psiquiátrica/estatística & dados numéricos , Feminino , Humanos , Incidência , Masculino , Pessoa de Meia-Idade , New England/epidemiologiaRESUMO
Two chronic schizophrenic out-patients with tardive dyskinesia were treated with chlorpromazine in 2 regimens -- once-daily and four times-daily -- using a cross-over design. Two "blind" raters evaluated the severity of symptoms of tardive dyskinesia, pseudoparkinsonism and schizophrenia on rating scales every week during the 14-week-trial period. Results showed that the intensity of dyskinesia was significantly lower, and that of pseudoparkinsonism higher (but not significantly) with Q.I.D. than with O.D. medication. Symptoms of schizophrenia did not vary in severity appreciably with the two frequencies of drug intake. It is suggested that multiple-dose administration of a phenothiazine maintains a steady level of dopamine blockade throughout the day and thus masks the manifestations of tardive dyskinesia.
